Blog

ActiGraph Announces Integration of Mobilise-D Algorithms in CentrePoint Platform

Written by ActiGraph | Jul 11, 2024 5:49:00 PM

ActiGraph is excited to announce the integration of Mobilise-D algorithms for digital mobility outcomes into our CentrePoint Cloud Platform. Measures of mobility are important functional outcomes, as mobility is a key indicator of health in many disease states and as we age. This was a driving factor behind the Mobilise-D consortium, bringing together over 300 research partners working together on a 5-year project (funded through the Innovative Medicines Initiative (IMI)) to generate device-agnostic, validated digital mobility measures to advance research in this area. 

Wearable digital health technology (DHT) offers a tool that is accurate, low burden, and can capture real-world measures of mobility. Over the course of the Mobilise-D project, the consortium used wearable DHTs to collect and validate digital mobility outcomes in healthy and disease populations. To prevent and treat mobility loss associated with aging and diseases such as chronic obstructive pulmonary disease (COPD), Parkinson’s disease (PD), multiple sclerosis (MS) and proximal femoral fracture (PFF), researchers can now use these validated tools to detect and measure walking and gait features.

To encourage broad adoption, the consortium has developed a device agnostic approach based on benchtop studies of research-grade devices including ActiGraph devices, and made the validated algorithms open source. We are excited to offer this solution using ActiGraph’s CentrePoint Cloud Platform and ActiGraph LEAP equipped with a new lumbar belt accessory.

Our data science team will implement the Mobilise-D algorithms using CentrePoint Designer, a new modular algorithm container system that allows third party algorithms to be easily configured and quickly deployed in isolation from the rest of the platform, leaving existing studies unaffected.

This comprehensive solution allows researchers to capture digital mobility outcomes using the most up-to-date and clinically validated Mobilise-D algorithms supported by ActiGraph’s state-of-the-art device hardware and innovative software platform.

 

Contact us today to discuss how we can support your study.